Induced Pluripotent Stem Cells: Global Markets Report 2017-2021

The Global Market for Induced Pluripotent Stem Cells (iPSCs) should reach $3.6 Billion in 2021, Increasing at a CAGR of 11.6% from 2016 through 2021

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered.

For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Overview

4: Induced Pluripotent Stem Cell Applications

5: Induced Pluripotent Stem Cell Market Segmentation and Forecast

6: Induced Pluripotent Stem Cell Research Application Market

7: Drug Discovery and Development Market

8: Induced Pluripotent Stem Cell Contract Service Market

9: Induced Pluripotent Stem Cell Clinical Application Market

10: Research Market Trend Analysis

11: Clinical Application Market Trend Analysis

12: Company Profiles

13: Conclusions

For more information about this report visit https://www.researchandmarkets.com/research/3ns6k3/induced

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716